disease-modifying antirheumatic drugsrheumatoid arthritisNuffield Orthopaedic CentreRABromley Research Ethics Committee
…A) is an unmet clinical need. Targeting joint inflammation with disease-modifying antirheumatic drugs has not resulted in the anticipated reduction in pain for many …